Cardinal Health Shares Outstanding 2012-2026 | CAH
Cardinal Health shares outstanding history from 2012 to 2026. Shares outstanding can be defined as the number of shares held by shareholders (including insiders) assuming conversion of all convertible debt, securities, warrants and options. This metric excludes the company's treasury shares.
- Cardinal Health shares outstanding for the quarter ending June 30, 2026 were 237M, a 2.07% decline year-over-year.
- Cardinal Health 2026 shares outstanding were 0.237B, a 2.07% decline from 2025.
- Cardinal Health 2025 shares outstanding were 0.242B, a 2.02% decline from 2024.
- Cardinal Health 2024 shares outstanding were 0.247B, a 5.73% decline from 2023.
|
Cardinal Health Annual Shares Outstanding (Millions of Shares) |
|
|---|---|
| 2026 | 237 |
| 2025 | 242 |
| 2024 | 247 |
| 2023 | 262 |
| 2022 | 279 |
| 2021 | 294 |
| 2020 | 293 |
| 2019 | 301 |
| 2018 | 315 |
| 2017 | 320 |
| 2016 | 330 |
| 2015 | 335 |
| 2014 | 345 |
| 2013 | 344 |
| 2012 | 349 |
|
Cardinal Health Quarterly Shares Outstanding (Millions of Shares) |
|
|---|---|
| 2026-06-30 | 237 |
| 2026-03-31 | 236 |
| 2025-12-31 | 237 |
| 2025-09-30 | 239 |
| 2025-06-30 | 242 |
| 2025-03-31 | 241 |
| 2024-12-31 | 243 |
| 2024-09-30 | 245 |
| 2024-06-30 | 247 |
| 2024-03-31 | 245 |
| 2023-12-31 | 246 |
| 2023-09-30 | 249 |
| 2023-06-30 | 262 |
| 2023-03-31 | 258 |
| 2022-12-31 | 261 |
| 2022-09-30 | 273 |
| 2022-06-30 | 279 |
| 2022-03-31 | 275 |
| 2021-12-31 | 281 |
| 2021-09-30 | 289 |
| 2021-06-30 | 294 |
| 2021-03-31 | 294 |
| 2020-12-31 | 295 |
| 2020-09-30 | 293 |
| 2020-06-30 | 293 |
| 2020-03-31 | 294 |
| 2019-12-31 | 294 |
| 2019-09-30 | 296 |
| 2019-06-30 | 301 |
| 2019-03-31 | 299 |
| 2018-12-31 | 300 |
| 2018-09-30 | 306 |
| 2018-06-30 | 315 |
| 2018-03-31 | 315 |
| 2017-12-31 | 316 |
| 2017-09-30 | 318 |
| 2017-06-30 | 320 |
| 2017-03-31 | 318 |
| 2016-12-31 | 319 |
| 2016-09-30 | 322 |
| 2016-06-30 | 330 |
| 2016-03-31 | 331 |
| 2015-12-31 | 332 |
| 2015-09-30 | 331 |
| 2015-06-30 | 335 |
| 2015-03-31 | 334 |
| 2014-12-31 | 334 |
| 2014-09-30 | 340 |
| 2014-06-30 | 345 |
| 2014-03-31 | 347 |
| 2013-12-31 | 346 |
| 2013-09-30 | 344 |
| 2013-06-30 | 344 |
| 2013-03-31 | 345 |
| 2012-12-31 | 343 |
| 2012-09-30 | 344 |
| 2012-06-30 | 349 |
| 2012-03-31 | 349 |
| 2011-12-31 | 349 |
| 2011-09-30 | 349 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical & Dental Supplies | $54.109B | $254.248B |
| Cardinal Health Inc. is a nation-wide drug distributor and provider of services to pharmacies, healthcare providers and manufacturers. The company has two reporting segments: Pharmaceutical and Medical. The Pharmaceutical segment is the second largest pharmaceutical distributor in the United States and the largest nuclear pharmacy. Its products and services include pharmaceutical distribution, manufacturer and specialty services, and nuclear and pharmacy services. The Medical segment manufactures products such as single-use surgical drapes, gowns and apparel; exam and surgical gloves; and fluid suction and collection systems and offers sterile and non-sterile procedure kits. These products are sold directly or distributed via third-party sources in the U.S., Canada, Europe, South America and the Asia/Pacific.? | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| McKesson (MCK) | United States | $104.880B | 22.04 |
| Becton Dickinson (BDX) | United States | $51.228B | 14.30 |
| West Pharmaceutical Services (WST) | United States | $25.687B | 42.94 |
| Straumann Holding AG (SAUHY) | Switzerland | $18.592B | 0.00 |
| Align Technology (ALGN) | United States | $10.528B | 16.28 |
| Cooper (COO) | United States | $10.130B | 11.56 |
| Henry Schein (HSIC) | United States | $9.754B | 16.48 |
| Merit Medical Systems (MMSI) | United States | $5.146B | 23.48 |
| DENTSPLY SIRONA (XRAY) | United States | $1.960B | 6.87 |
| CONMED (CNMD) | United States | $1.406B | 9.82 |
| STAAR Surgical (STAA) | United States | $1.125B | 35.07 |
| Pro-Dex (PDEX) | United States | $0.214B | 19.97 |
| Lifevantage (LFVN) | United States | $0.077B | 11.04 |